Rontalizumab

rontalizumab · Genentech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rontalizumab, covering 2016-08-12 to 2016-08-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Rontalizumab in Patients With Moderately to Severely Active Systemic Lupus Erythematosus [Phase 2]

See pricing